If you could have one wish for global public health, what would it be? If you’re like us at Maternova, you’re just tired of waiting for help to arrive. If you are, you’ll love our new undertaking. We are frustrated daily with the bureaucracy and red tape involved in saving lives. When did forms supersede the value of a newborn life? And why are people so afraid of innovation they cling to outdated devices, practices and policies – when the answers they are seeking are right in front of them? Unfortunately, we haven’t gotten their attention yet.
Not ones to sit around waiting, we’re doing something unusual. We’re partnering with Dr. Sophie Webster, maverick Obstetrician/Gynecologist and Cessna plane pilot to shorten the time women and newborns in need.
We need **YOUR** help to do it. Visit our [Catapult Project Page here](http://www.catapult.org/project/taking-flight-save-moms-and-newborns), and read how we’re taking direct action to save more lives than ever before. Consider making a tax deductible donation to Maternova Research, let’s get ready for take off. Buckle up, it may be bumpy, but we’re excited to share this wonderful journey with you.
**Thank you for not only sharing this within your own networks, but for your continued support.**
Postpartum depression (PPD) affects 1 in 7 new mothers and can lead to severe risks for both mother and baby if untreated. In 2019, the FDA approved Zulresso, a costly hospital-administered drug. Recently, the FDA approved Zurzuvae, the first oral PPD treatment, offering a more accessible and home-based option.